200 related articles for article (PubMed ID: 3918553)
1. Antinuclear antibodies in the relatives of patients with systemic sclerosis.
Takehara K; Moroi Y; Ishibashi Y
Br J Dermatol; 1985 Jan; 112(1):23-33. PubMed ID: 3918553
[TBL] [Abstract][Full Text] [Related]
2. Antinuclear antibodies in localized scleroderma.
Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
[TBL] [Abstract][Full Text] [Related]
3. Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies.
French MA; Harrison G; Penning CA; Cunningham J; Hughes P; Rowell NR
Ann Rheum Dis; 1985 Feb; 44(2):89-92. PubMed ID: 3919660
[TBL] [Abstract][Full Text] [Related]
4. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
5. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.
Maddison PJ; Skinner RP; Pereira RS; Black CM; Ansell BM; Jayson MI; Rowell NR; Welsh KI
Ann Rheum Dis; 1986 Oct; 45(10):793-9. PubMed ID: 3098192
[TBL] [Abstract][Full Text] [Related]
7. Antinuclear antibodies in progressive systemic sclerosis.
Riboldi P; Asero R; Origgi L; Crespi S; Meroni PL; Sguotti C; Sabbadini MG
Clin Exp Rheumatol; 1985; 3(3):205-11. PubMed ID: 3902296
[TBL] [Abstract][Full Text] [Related]
8. Serological markers in progressive systemic sclerosis: clinical correlations.
Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
[TBL] [Abstract][Full Text] [Related]
9. Clinical subsets of scleroderma: relevance of fluorescent and precipitating antinuclear antibodies.
Cassani F; Tosti A; Bianchi FB; Fusconi M; Selleri L; Baffoni L; Veronesi S; Volta U; Lenzi M; Pisi E
Clin Exp Rheumatol; 1987; 5(1):23-8. PubMed ID: 3109797
[TBL] [Abstract][Full Text] [Related]
10. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.
Tan EM; Rodnan GP; Garcia I; Moroi Y; Fritzler MJ; Peebles C
Arthritis Rheum; 1980 Jun; 23(6):617-25. PubMed ID: 6155920
[TBL] [Abstract][Full Text] [Related]
11. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
12. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
[TBL] [Abstract][Full Text] [Related]
13. Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.
Barnett AJ; McNeilage LJ
Ann Rheum Dis; 1993 May; 52(5):365-8. PubMed ID: 8323384
[TBL] [Abstract][Full Text] [Related]
14. Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.
Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski T; Jabłońska S; Maul GG
Arch Dermatol Res; 1990; 282(2):76-83. PubMed ID: 2162156
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G subclass distribution of autoantibodies in systemic sclerosis, primary biliary cirrhosis, and overlap syndromes.
French MA; Bernstein RM
Ann Rheum Dis; 1987 Jun; 46(6):436-40. PubMed ID: 3115201
[TBL] [Abstract][Full Text] [Related]
16. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
Harvey G; Black C; Maddison P; McHugh N
J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis.
Igarashi A; Takehara K; Soma Y; Kikuchi K; Ishibashi Y
Dermatologica; 1990; 180(3):136-40. PubMed ID: 2340922
[TBL] [Abstract][Full Text] [Related]
18. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate].
Lüthke K; Conrad K; Frank KH
Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies detected by indirect immunofluorescence on HEp2 cells and by immunoblotting in patients with systemic sclerosis.
Briolay J; Gioud M; Monier JC; Rodde JL; Cohen J; Roux B; Kaliss B
Autoimmunity; 1989; 2(2):165-76. PubMed ID: 2491600
[TBL] [Abstract][Full Text] [Related]
20. Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations.
Aeschlimann A; Meyer O; Bourgeois P; Haim T; Belmatoug N; Palazzo E; Kahn MF
Ann Rheum Dis; 1989 Dec; 48(12):992-7. PubMed ID: 2515813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
